Market Forecast News: Minimally Invasive Surgery Industry to Hit $199.30B by 2030
The report "Minimally Invasive Surgery Market By Type (Surgical Device, Imaging System, Electrosurgical Device, Endoscopy Device, Medical Robotics), Application (Urological, Vascular, Oncological), End User (Hospital, Clinic, ASC), Region—Global Forecast to 2030", is projected to reach USD 199.30 billion by 2030 from USD 94.45 billion in 2025, at a CAGR of 16.1% from 2025 to 2030.
Browse 459 market data tables and 60 figures spread through 389 pages and in-depth TOC on the "Minimally Invasive Surgery Market – Global Forecast to 2030.”
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/minimally-invasive-medical-robotics-imaging-visualization-systems-market-787.html
The growth of the minimally invasive surgery market is fueled by the shift from open surgeries to MIS, driven by benefits like reduced pain, shorter hospital stays, quicker recovery, and fewer complications. Both surgeons and patients favor MIS for its clinical and economic benefits. Furthermore, increased healthcare investments, improved infrastructure, and rising awareness in emerging markets create significant opportunities for MIS product manufacturers. Greater adoption in these regions, supportive regulations, and demand for affordable surgical options will likely boost market growth.
By product, the surgical devices segment accounted for the largest share in 2024.
On the basis of product, the global minimally invasive surgery market is segmented into surgical devices, imaging and visualization systems, electrosurgical devices, endoscopy devices, and medical robotics. Among these, in 2024, the surgical devices segment held the largest market share. This is because of its crucial role in all MIS procedures and ongoing product innovation. The rising number of surgical procedures worldwide and the widespread adoption of affordable, articulating laparoscopic handheld instruments are fueling demand. Electrosurgical devices, in particular, are experiencing rapid growth due to their high usage volume and versatility across various procedures. Improvements in handheld instrument design—such as better ergonomics, precision, and reusable options—boost surgical efficiency and user comfort. Additional factors like ease of sterilization, durability, surgeon familiarity, and compliance with evolving regulations also promote widespread adoption. Intense competition among manufacturers further drives continuous improvements, strengthening the segment's market position.
By application, the gastrointestinal & abdominal surgery segment accounted for the largest share in 2024.
On the basis of application, the minimally invasive surgery market is segmented into cardiothoracic surgery, vascular surgery, neurological surgery, ENT & respiratory surgery, cosmetic surgery, gastrointestinal & abdominal surgery, gynecological surgery, urological surgery, orthopedic surgery, oncology surgery, dental surgery, and other surgeries. Among these, in 2024, the gastrointestinal & abdominal surgery segment held the largest market share, due to the high global burden of GI diseases and increasing surgical volumes. According to the American Gastroenterological Association, 315,065 new GI cancer cases were diagnosed, and 281,413 related deaths occurred, emphasizing the need for timely intervention. In 2022 alone, an estimated 23.5 million GI endoscopies were performed, reflecting the demand for minimally invasive diagnostic and therapeutic procedures. MIS techniques in GI and abdominal surgeries offer significant advantages, including reduced postoperative complications, quicker recovery, and shorter hospital stays. These benefits and the rising adoption of laparoscopic and robotic-assisted procedures for colorectal, bariatric, and hepatobiliary surgeries contribute to segment dominance. Technological advancements, increasing awareness, and expanding healthcare access reinforce market leadership.
North America dominated the global minimally invasive surgery market in 2024.
The minimally invasive surgery market is divided into five main regional segments: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest share in 2024 of the global minimally invasive surgery market. This is due to the high prevalence of chronic diseases and the widespread adoption of advanced surgical technologies. According to the American Cancer Society, an estimated 2,041,910 new cancer cases and 618,120 cancer-related deaths are expected in the U.S. in 2025. Additionally, the CDC reported 919,032 cardiovascular-related deaths in 2023, with someone dying every 34 seconds. This increasing disease burden boosts the demand for effective, less invasive surgical options. The region also benefits from a well-established healthcare infrastructure, favorable reimbursement policies, and high healthcare spending. Furthermore, growing patient preference for minimally invasive surgery over open procedures—because of faster recovery and lower risks—also drives market growth. Coupled with substantial R&D investments and the presence of major medical device manufacturers, these factors strengthen North America’s leadership position in the global minimally invasive surgery market.
Some of the prominent players operating in the market include Medtronic (Ireland), Johnson & Johnson (US), Stryker (US), Boston Scientific Corporation (US), Siemens Healthineers AG (Germany), Abbott (US), GE HealthCare (US), Koninklijke Philips N.V. (Netherland), Intuitive Surgical Operations, Inc. (US), FUJIFILM Corporation (Japan), and among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Minimally Invasive Surgery Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
